 |
|
|
|
  
|
|
|
|
marketRx Inc. Named One of New Jersey's Fastest Growing Technology Companies in Deloitte's Technology Fast 50 Program
August 10, 2006,
Bridgewater, NJ - marketRx Inc., has been named one of the Fastest Growing
Technology Company in Deloitte's technology Fast 50 program for New Jersey, a
ranking of the 50 fastest growing technology companies in the area by Deloitte
& Touché USA LLP, one of the nation's leading professional services
organizations. The rankings are based on the percentage revenue growth over
five years from 2001-2005.
marketRx Inc, based at Bridgewater, New Jersey, is a leading provider of specialized Sales and Marketing Effectiveness Solutions to the global Pharmaceutical and Biotechnology companies. Our business delivery model combines extensive industry knowledge with global online market research and analytical expertise to deliver actionable solutions in sales force strategy, sales management tactical planning, targeting, brand management, quick-turnaround market research, segmentation, sales and marketing metrics, forecasting and brand tracking. Today, in just six years, more than 60 global pharmaceutical companies, including all of the top 20 are leveraging marketRx's innovative ROI-driven sales and marketing effectiveness solutions at a global level.
marketRx's President & CEO Mr. Jaswinder Chadha (Jassi) credits an unwavering dedication & commitment of his employees & big investments in developing proprietary tools for resounding revenue growth in excess of 836% during 2001-2005 period. "We are honored to be recognized by Deloitte for our strong performance and our growth and success in such a short span is all because of our strong management team and committed employees. I believe that the practice of inspiring brightest minds by offering right challenges and a freedom to resolve them without a fear of failure or hesitation of committing a mistake is what drives marketRx's success. I am proud to be part of such a team" said Jassi.
"Deloitte's New Jersey Technology Fast 50 companies have shown the strength, vision and tenacity to succeed in today's very competitive technology environment," said Paul Mlynarski, a Partner at Deloitte Tax LLP and Chairperson of Deloitte's New Jersey Technology Fast 50 Program. "In an era where technology companies come and go, making the Deloitte Fast 50 is a testament to a company's vision that allows growth year after year. We applaud the successes of marketRx Inc. and acknowledge it as one of the very few to accomplish such a fast growth rate over the past five years."
marketRx's increase in revenues of more than 836% from 2001 to 2005 resulted in our ranking amongst top 20 in the Technology Fast 50 for New Jersey The average revenue growth among companies who made the Technology Fast 50 for this region was 527% percent.
To qualify for the Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2001 and $5,000,000 in 2005, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify.
Winners of the 16 regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology, media, telecommunications and life sciences companies. For more information on Deloitte's Technology Fast 50 or Technology Fast 500 programs, visit www.fast500.com
About
marketRx
marketRx combines analytics, market research and technology to provide solutions that enable our customers at global pharmaceutical and biotechnology companies to improve the effectiveness of their sales and marketing initiatives.
Our business delivery model combines extensive industry knowledge with global online market research and analytical expertise to deliver actionable solutions in sales force strategy, tactical planning, targeting, brand management, quick-turnaround market research, segmentation, sales and marketing metrics, forecasting and brand tracking. Our technology enabled solutions also enable our customers to build internal capabilities by leveraging our R&D focus.
With all of the top-20 global pharmaceutical companies as customers and experience in more than 20 different countries, marketRx is the leading provider of integrated sales and marketing effectiveness solutions.
Contact:
Vikas Vats
marketRx, Inc.
marketing@marketrx.com
908-541-0045
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte", "Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.
Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP.
Press releases
|
|
|
| |
|
|
© 2000-2010 marketRx, Inc. All rights reserved.
